N,N-Dimethylethanaminium

N,N-Dimethylethanaminium

SCHEMBL352062

CCN(C)C

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230104690-A1 MATRIX METALLOPROTEINASE INHIBITORS (MMPIs) BRANDON UNIV (CA) 2023-04-06 US disclosed
WO-2022000071-A1 MATRIX METALLOPROTEINASE INHIBITORS (MMPIS) BRANDON UNIVERSITY (CA) 2022-01-06 WO disclosed
US-20200316865-A1 METHODS AND SYSTEMS FOR STEREOLITHOGRAPHY THREE-DIMENSIONAL PRINTING Southwest Greene International, Inc. 2020-10-08 US disclosed
CN-103492569-B Base-modified oligonucleotides 米拉根医疗公司 2020-04-07 CN disclosed
US-20190176398-A1 METHODS AND SYSTEMS FOR STEROLITHOGRAPHY THREE-DIMENSIONAL PRINTING HOLO, INC. 2019-06-13 US disclosed
US-10245785-B2 Methods for stereolithography three-dimensional printing HOLO, INC. (US) 2019-04-02 US disclosed
US-20180361666-A1 METHODS AND SYSTEMS FOR STEREOLITHOGRAPHY THREE-DIMENSIONAL PRINTING Southwest Greene International, Inc. 2018-12-20 US disclosed
EP-3415151-A1 MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES The University of British Columbia (CA) 2018-12-19 EP disclosed
EP-2282724-B1 MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES UNIV BRITISH COLUMBIA (CA) 2018-09-05 EP disclosed
US-20180221279-A1 MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES UNIV BRITISH COLUMBIA (CA) 2018-08-09 US disclosed
US-20060293345-A1 Heterobicyclic metalloprotease inhibitors ALANTOS PHARMACEUTICALS HOLDING, INC. 2006-12-28 US disclosed
WO-2006128184-A2 PYRIMIDINE OR TRIAZINE FUSED BICYCLIC METALLOPROTEASE INHIBITORS ALANTOS-PHARMACEUTICALS, INC. (US) 2006-11-30 WO disclosed
US-20060270701-A1 Dipeptidyl peptidase-IV inhibitors ALANTOS PHARMACEUTICALS, INC. 2006-11-30 US disclosed
WO-2006116157-A2 DIPEPTIDYL PEPTIDASE-IV INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2006-11-02 WO disclosed
WO-2006083454-A1 MULTICYCLIC BIS-AMIDE MMP INHIBITORS ALANTOS PHARMACEUTICALS, INC. (US) 2006-08-10 WO disclosed
US-20060173183-A1 Multicyclic bis-amide MMP inhibitors ALANTOS PHARMACEUTICALS, INC., 2006-08-03 US disclosed
US-6599958-B2 A) polymeric compound, especially an acrylate; b) a photoinitiator, especially a phosphinate or phosphine oxide; and c) a photoaccelerator, especially aliphatic amines and aromatic amines. GEL PRODUCTS, INC. 2003-07-29 US disclosed
US-6481444-B1 Finishing compounds for radiation curable nail coatings GEL PRODUCTS, INC. 2002-11-19 US disclosed
US-6391938-B1 CONTAINING METHACRYOYLOXYETHYL PHTHALATE GEL PRODUCTS, INC. 2002-05-21 US disclosed
US-5279921-A Pattern formation resist and pattern formation method KABUSHIKI KAISHA TOSHIBA (JP) 1994-01-18 US disclosed